CNST - Constellation Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
Total Revenue
0
0
0
0
Cost of Revenue
-
-
-
-
Gross Profit
-
-
-
-
Operating Expenses
Research Development
60,991
48,769
32,617
27,881
Selling General and Administrative
17,001
12,475
6,471
5,777
Total Operating Expenses
77,992
61,244
39,088
33,658
Operating Income or Loss
-77,992
-61,244
-39,088
-33,658
Interest Expense
660
228
901
1,345
Total Other Income/Expenses Net
-
-
4,443
417
Income Before Tax
-76,075
-59,925
-35,377
-34,533
Income Tax Expense
-
-
-
-
Income from Continuing Operations
-76,075
-59,925
-35,377
-34,533
Net Income
-76,075
-59,925
-35,377
-34,533
Net Income available to common shareholders
-76,075
-59,925
-39,792
-49,465
Reported EPS
Basic
-
-5.00
-3.40
-45.52
Diluted
-
-5.00
-3.40
-45.52
Weighted average shares outstanding
Basic
-
11,984
11,690
1,087
Diluted
-
11,984
11,690
1,087
EBITDA
-
-59,135
-34,002
-32,985